Aristotle University Of Thessaloniki (AUTH)
Ανάπτυξη και χαρακτηρισμός φαρμακομορφών για παρειακή χορήγηση με τη χρήση δισδιάστατης και τρισδιάστατης εκτύπωσης
Abstract
dc:descriptionPersonalized treatments afford an innovative and constantly evolving approach in health sciences, while being explored by researchers globally, in order to develop novel pharmaceuticals and treatments, as well as to improve the quality of life of individuals. In the context of personalized treatments, the patient is considered individually by taking into account physiological factors, such as gender, age, habits, as well as factors related to special populations, such as infants and the elderly. Personalization of the treatment provides the capability to determine the variability of symptoms of individuals, to adjust the dosage characteristics on-demand, and to co-administer more than one active ingredient. The development of state-of-the-art formulation processes, i.e. two-dimensional and three-dimensional printing, was key to the adoption of personalization in therapeutic approaches. Moreover, a wide range of the conducted research has been focused on further modifications and improvements of these technologies, to develop hybrid formulation processes and hybrid drug delivery systems. During the last decade, the two-dimensional printing technology has focused the interest of pharmaceutical research, due to the facile design and modification of digital patterns. The nature of this technology was gradually linked with the on-demand manufacturing of drug formulations and contributed to the personalization of the dose of the active compound and the divergence from the mass production of ‘one-size-fits-all’ products. The three-dimensional printing technology, belonging to the family of additive manufacturing processes, has recently emerged in the context of manufacturing trends. This technology is described by a broad range of scientific, industrial and social applications, providing the ability of rapid prototyping of objects, and, thus, was definitely adopted in the field of pharmaceutical technology. The approval of the first three-dimensionally printed pharmaceutical product (Spritam®, Aprecia Pharmaceuticals) from the FDA further incited the incorporation of this technology in the pharmaceutical field. However, the range of applications of the printing technologies has not uncovered their true potential, as an array of new approaches is still being explored. This fact reveals the evolving nature of the research activities, related to the incorporation of state-of-the-art technologies in the pharmaceutical field, and thus the gradual establishment of two- and three-dimensional printing technologies in the field of standard processes for pharmaceutical manufacturing. The scope of the current doctoral thesis has been determined, in accordance with the facts described in the previous sections, as a research and exploitation methodology of two- and three-dimensional printing technologies in the development of novel drug formulations, intended for the buccal administration of pharmaceutical compounds. Furthermore, the capabilities of coupling these technologies was explored as a unified manufacturing process, whereas alternative approaches in the application of three-dimensional printing in pharmaceutics has been further investigated. Three formulations for the buccal administration of active compounds were developed in the context of the doctoral thesis. The first formulation has been specifically prepared via the three-dimensional printing technique, to approach the development of multilayered buccal films, loaded with diclofenac sodium, with simultaneous incorporation of various concentrations of a permeation enhancer, and the additional manufacturing of a backing layer to promote the unidirectional release of the drug. The second study aimed to couple the two-dimensional inkjet printing with the fused deposition modeling technique, and the investigation of the interaction of these manufacturing methods, to achieve the incorporation of a thermosensitive active compound (ibuprofen) in the buccal films. In the third study, the two-dimensional and three-dimensional printing technologies were coupled, to utilize the capabilities of each method in the simultaneous incorporation of thermosensitive and thermostable active compounds (lidocaine hydrochloride and ketoprofen, respectively), the incorporation of a thermosensitive permeation enhancer (l-menthol), and the fabrication of a backing layer, to achieve the local co-administration of the substances in the buccal mucosa. In the context of conducting this doctoral thesis, an array of physicochemical and mechanical characterizations were carried out, as was as a broad range of in vitro and ex vivo studies, to evaluate and establish the individual or combinatorial utilization of the capabilities of two- and three- dimensional printing on the development of on-demand drug delivery systems intended for buccal administration.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Eleftheriadis, Georgios
- Ελευθεριάδης, Γεώργιος
Subjects
dc:subject × 14Rights
dc:rights- Statement dc:rights
-
- BY_NC_ND
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/47128